PD1A Stock Chart & Stats
€19.40
-€0.20(-1.02%)
At close: 4:00 PM EDT
€19.40
-€0.20(-1.02%)
Day’s Range― - ―
52-Week Range€15.20 - €21.00
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€2.76B
Enterprise Value€6.00K
Total Cash (Recent Filing)€254.17M
Total Debt (Recent Filing)€912.82M
Price to Earnings (P/E)24.0
Beta0.59
Next Earnings
Aug 24, 2026EPS Estimate
0.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.96
Shares Outstanding140,313,830
10 Day Avg. Volume0
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG Ratio1.53
Price to Book (P/B)1.47
Price to Sales (P/S)1.45
P/FCF Ratio17.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€20.89Price Target Upside7.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)0.94
Revenue Forecast (FY)€1.33B
Bulls Say, Bears Say
Bulls Say
Sustained Margin ExpansionMaterial margin expansion (GPADE +220bps; EBIT margin 14.3%) reflects lasting improvements from pricing, procurement and productivity. Higher structural margins increase resilience to input cost and FX shocks, support reinvestment and dividend/buyback capacity, and raise long-term cash conversion potential.
Strong Cash Conversion & Solid Balance SheetA 112% cash conversion rate and modest net leverage (~1.5x) indicate durable cash generation and financial flexibility. This supports sustained capex for new lines, M&A integration, and capital returns while preserving ability to absorb cyclical shocks or tariff-related costs without forcing aggressive balance sheet actions.
Successful Integration And Product InnovationRapid KBU integration with realized synergies and new product launches plus India manufacturing provide structural benefits: broader differentiated portfolio, cross-sell opportunities, and improved supply/cost positioning. These durable capabilities support higher-margin growth and reduce reliance on commodity products over time.
Bears Say
Significant Tariff ExposureAn $80M annualized U.S. tariff is a persistent structural headwind that raises unit costs and forces ongoing price adjustments. Even if management offsets some impact, tariffs can permanently weaken demand in price-sensitive export markets, raise working capital needs, and compress long-run volume and margin in exposed geographies.
Decline In Free Cash Flow GrowthA 22.7% decline in free cash flow growth signals weakening ability to convert earnings into discretionary cash. Over months this constrains funding for capex, acquisitions, buybacks or debt reduction, reducing strategic optionality if headwinds persist or if integration and tariff mitigation cost more than planned.
Commodity Glove Volume WeaknessOngoing volume declines in commodity exam gloves highlight structural demand and pricing sensitivity in low‑differentiation products. Persistent weakness here pressures top-line stability and overall margins unless the company successfully shifts mix toward differentiated, higher‑margin products and industrial segments.
Ansell News
PD1A FAQ
What was Ansell’s price range in the past 12 months?
Ansell lowest stock price was €15.20 and its highest was €21.00 in the past 12 months.
What is Ansell’s market cap?
Ansell’s market cap is €2.76B.
When is Ansell’s upcoming earnings report date?
Ansell’s upcoming earnings report date is Aug 24, 2026 which is in 26 days.
How were Ansell’s earnings last quarter?
Ansell released its earnings results on Feb 15, 2026. The company reported €0.582 earnings per share for the quarter, beating the consensus estimate of €0.56 by €0.022.
Is Ansell overvalued?
According to Wall Street analysts Ansell’s price is currently Undervalued.
Does Ansell pay dividends?
Ansell does not currently pay dividends.
What is Ansell’s EPS estimate?
Ansell’s EPS estimate is 0.67.
How many shares outstanding does Ansell have?
Ansell has 140,313,830 shares outstanding.
What happened to Ansell’s price movement after its last earnings report?
Ansell reported an EPS of €0.582 in its last earnings report, beating expectations of €0.56. Following the earnings report the stock price went up 8.585%.
Which hedge fund is a major shareholder of Ansell?
Currently, no hedge funds are holding shares in DE:PD1A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ansell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.18%
12-Months-Change
Fundamentals
Return on Equity
2.34%
Trailing 12-Months
Asset Growth
1.60%
Trailing 12-Months
Company Description
Ansell
Ansell Limited is a global enterprise that conceptualizes, innovates, and produces protective equipment for various industries across numerous regions, including Asia Pacific, Europe, the Middle East, Africa, the Americas, and the Caribbean. The company's operations are divided into two principal divisions: Healthcare and Industrial. The Healthcare division focuses on crafting and distributing products such as surgical, single-use, and examination gloves, alongside specialized cleanroom and sterile gloves and apparel. These offerings cater to a diverse clientele including medical facilities, surgical clinics, dental offices, veterinary practices, emergency services, research laboratories, and pharmaceutical and life science firms. Conversely, the Industrial segment provides hand and chemical protective gear designed for a wide array of demanding applications, from the automotive, chemical, and metal fabrication sectors to machinery, food processing, construction, mining, oil and gas industries, and first responders. Established in 1893 and headquartered in Richmond, Australia, the company was initially known as Pacific Dunlop Limited before rebranding to Ansell Limited in 2002. P. D. Holdings Pty. Ltd. currently operates as a subsidiary of Ansell Limited.
PD1A Stock 12 Month Forecast
Average Price Target
€20.89
▲(7.67% Upside)
Technical Analysis
Nanosonics Limited
―
Medical Developments International Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―